Request Discount

Invasive Fungal Infection Market (Disease Type - Candidaemi Caa and Invasive Candiasis, Intra-abdominal Candiasis, Cryptococcal Meningitis, Esophageal Candidiasis, Histoplasmosis Acute Pulmonary, Invasive Aspergillosis, Invasive Rhinosinusitis, Mucormycosis, and Others; Drug Type - Polyenes, Amphotericin B Deoxycholate, Lipid Formulation Amphotericin B, and Others): Global Industry Analysis, Trends, Size, Share and Forecasts to 2027

  • Published : February, 2022

  • Rep Id : HC08737

  • Category : Healthcare & Medical Devices

  • Status : Published

A recent report published by Infinium Global Research on the invasive fungal infection market provides in-depth analysis of segments and sub-segments in the global as well as regional invasive fungal infection market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional invasive fungal infection market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global invasive fungal infection market. According to the report, the global invasive fungal infection market is projected to reach USD 8 billion by 2027 from USD 6 billion in 2021, growing with a CAGR of 4% over the forecast period of 2021-2027.


Market Insight

Fungi are freely present in the environment, a versatile group of microorganisms, and can be part of the normal flora of humans and animals. Fungi can cause mild superficial infections to serve life-threatening invasive conditions. The diseases where fungi have invaded the deep tissues and have established themselves, resulting in prolonged illness, are known as invasive fungal infections (IFI’s). Furthermore, in debilitated and immunosuppressed individuals, the IFI’s can be seen usually, and many reports have shown that even in immunocompetent individuals. Hence IFI’s becomes a potential threat in the present century. Furthermore, fungi have evolved mechanisms to survive in the mammalian hosts, which are considered saprophytic microorganisms. Most of the time, fungal infections spread accidentally, and systemic fungal infections spread rarely but can result in high mortality. In the case of systematic fungal infections, the outcome of the disease depends more on the host factors than the fungal virulence. Moreover, fungi invading often goes unrecognized by the immune system, and such invasive fungal infections can result in severe inflammatory reactions resulting in morbidity and mortality. Additionally, fungi were uncommon during the earlier part of the 20th century when the world was plagued with bacterial epidemics, but now fungi have become a major global health problem.


There are many discoveries and advancements in pipeline drugs and facilities provided by hospitals in intensive care units for those who have undergone surgery. Furthermore, there is a rise in the population suffering from HIV, for which there is increased use of broad-spectrum antibiotics. Moreover, dramatic growth in the global economy has been seen in the last few years. All these factors are expected to accelerate the development of the invasive fungal infection market. Also, there has been seen an increasing advancement in pipeline drugs used to treat fungal infection; hence, this advancement is projected to drive the market’s growth. On the other hand, there are many consequences that patients might have to face during immunosuppressive treatment of fungal infection, and due to which the growth of the invasive fungal infection market can be hampered. Nevertheless, the rising disposable income of people has been seen in the past few years. Hence, people can spend more on their treatment, which is an excellent opportunity for the invasive fungal infection market.


The invasive fungal infection market is segmented into North America, Europe, Asia Pacific, and the rest of the world. North America dominates the market by holding the largest globally invasive fungal infection market. Due to the high prevalence of invasive fungal infection raising public awareness of invasive fungal diseases, the North American region is witnessing tremendous market growth. For instance, the centers for Disease Control and Prevention stated that Invasive fungal disorders cause significant morbidity and mortality, and hence awareness is necessary for early diagnosis and treatment. The people in North America are more aware of such fungal diseases, which helps the invasive fungal infection market grow in the region. Furthermore, Europe is expected to hold the second-largest market share due to an increase in healthcare infrastructure, a rise in healthcare expenditure, a growing number of patients suffering from fungal infections, and others. Moreover, Asia Pacific is also expected to earn the highest CAGR during the forecast period due to the higher prevalence of fungal diseases and infections, government support, and others. For instance, the Government of India has come up with a public-private partnership (PPP) due to an increase in the cases of fungal infections in India; hence it is mainly influencing the growth opportunities of the market for India.


Invasive Fungal Infection Market

Segment Covered

The report on the global invasive fungal infection market covers segments such as disease type, and drug type. On the basis of disease type, the sub-markets include candidaemi Caa and invasive candiasis, intra-abdominal candiasis, cryptococcal meningitis, esophageal candidiasis, histoplasmosis acute pulmonary, invasive aspergillosis, invasive rhinosinusitis, mucormycosis, and others. On the basis of drug type, the sub-markets include polyenes, amphotericin b deoxycholate, lipid formulation amphotericin b, and others.


Companies Profiled:

The report provides profiles of the companies in the market such as Cidara, Basilea Pharmaceutica, Pfizer, GlaxoSmith Kline, Bayer AG, Abbott, Merck & Co., Astellas Pharma Inc., and Scynexis Inc.


Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the invasive fungal infection market. Moreover, the study highlights current market trends and provides forecast from 2021-2027. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.

Other Reports in This Category
24 hour delivery through email
9923950043 Monday to Frieday 9am-7pm
looking for discount